Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress

Table 1

MicroRNAs	Regulation	Sources	Association	Methods	Study population	Number of samples	Potential value	Reference
miR-208b, miR-208a, and miR-499	Up	Serum and plasma	NT-proBNP	A miRNA array/qRT-PCR	Human		Diagnostic/prognostic	[3, 20]
miR-423-5p	Up	Plasma	NT-proBNP	A miRNA array/qRT-PCR	Human		Diagnostic	[24, 54]
miR-133	Down	Plasma	NT-proBNP	qRT-PCR	Human		Diagnostic	[55]
miR-103, miR-142-3p, miR-30b, and miR-342-3p	Down	Plasma	NT-proBNP	A miRNA array/qRT-PCR	Human		Diagnostic	[56]
miR-126	Down	Plasma	NT-proBNP	qRT-PCR	Human		Diagnostic	[57]
miR-210 and miR-30a	Up	Serum	NT-proBNP	qRT-PCR	Human		Diagnostic	[58]
miR-192	Up						Prognostic	[59]
miR-26b-5p, miR-145-5p, miR-92a-3p, miR-30e-5p, and miR-29a-3p	Up	Plasma	NT-proBNP	A miRNA array/qRT-PCR	Human		Prognostic	[60]
miR-483-3p	Up	Plasma	NT-proBNP	Microarray assay	Human		Prognostic	[61]